HDST.M Stock Chart & Stats
64.80
4.00(6.58%)
At close: 4:00 PM EDT
64.80
4.00(6.58%)
Day’s Range― - ―
52-Week Range30.00 - 85.00
Previous CloseN/A
Volume4.93K
Average Volume (3M)4.48K
Market Cap
₪7.19M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,088,522
10 Day Avg. Volume8,069
30 Day Avg. Volume4,482
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HDST.M FAQ
What was HBL- Hadasit Bio-Holdings Ltd.’s price range in the past 12 months?
HBL- Hadasit Bio-Holdings Ltd. lowest stock price was 30.00 and its highest was 85.00 in the past 12 months.
What is HBL- Hadasit Bio-Holdings Ltd.’s market cap?
HBL- Hadasit Bio-Holdings Ltd.’s market cap is ₪7.19M.
When is HBL- Hadasit Bio-Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HBL- Hadasit Bio-Holdings Ltd.’s earnings last quarter?
HBL- Hadasit Bio-Holdings Ltd. released its earnings results on Aug 19, 2021. The company reported 221.4 earnings per share for the quarter.
Is HBL- Hadasit Bio-Holdings Ltd. overvalued?
According to Wall Street analysts HBL- Hadasit Bio-Holdings Ltd.’s price is currently Overvalued.
Does HBL- Hadasit Bio-Holdings Ltd. pay dividends?
HBL- Hadasit Bio-Holdings Ltd. does not currently pay dividends.
What is HBL- Hadasit Bio-Holdings Ltd.’s EPS estimate?
HBL- Hadasit Bio-Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HBL- Hadasit Bio-Holdings Ltd. have?
HBL- Hadasit Bio-Holdings Ltd. has 11,088,522 shares outstanding.
What happened to HBL- Hadasit Bio-Holdings Ltd.’s price movement after its last earnings report?
HBL- Hadasit Bio-Holdings Ltd. reported an EPS of 221.4 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of HBL- Hadasit Bio-Holdings Ltd.?
Currently, no hedge funds are holding shares in IL:HDST.M
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HBL- Hadasit Bio-Holdings Ltd.
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.